title: Clopidogrel and neuraxial block: the role of the PFA II and P2Y12 assays.
authors.forename: Honorio T
authors.initials: HT
authors.lastname: Benzon
authors.forename: Robert
authors.initials: R
authors.lastname: Fragen
authors.forename: Hubert A
authors.initials: HA
authors.lastname: Benzon
authors.forename: Jason
authors.initials: J
authors.lastname: Savage
authors.forename: Jennifer
authors.initials: J
authors.lastname: Robinson
authors.forename: Lalit
authors.initials: L
authors.lastname: Puri
mesh_terms: D000368:Aged; D000077144:Clopidogrel; D005265:Femoral Neck Fractures / Q000601:surgery; D006801:Humans; D008297:Male; D009407:Nerve Block / Q000379:methods*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D010979:Platelet Function Tests; D018048:Receptors, Purinergic P2 / Q000378:metabolism*; D058925:Receptors, Purinergic P2Y12; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: C548576:P2RY12 protein, human; D010975:Platelet Aggregation Inhibitors; D018048:Receptors, Purinergic P2; D058925:Receptors, Purinergic P2Y12; D000077144:Clopidogrel; D013988:Ticlopidine